Stocks
Walgreens Boots Alliance Financial Statements (WBA) |
||||||||||
| Walgreens Boots Alliancesmart-lab.ru | % | 2022 | 2022 | 2023 | 2023 | 2024 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 13.10.2022 | 23.11.2022 | 12.10.2023 | 22.11.2023 | 15.10.2024 | 15.10.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 132 703 | 132 703 | 139 081 | 139 081 | 147 658 | 147 657 | |||
| Operating Income, bln rub | 1 387 | 4 385 | -6 882 | -6 882 | -14 076 | -14 076 | ||||
| EBITDA, bln rub | ? | 4 955 | 6 375 | -2 582 | 3 479 | -11 278 | -11 534 | |||
| Net profit, bln rub | ? | 4 337 | 4 337 | -3 080 | -3 080 | -8 636 | -8 636 | |||
| OCF, bln rub | ? | 3 899 | 3 899 | 2 258 | 2 258 | 1 018 | 1 018 | |||
| CAPEX, bln rub | ? | 1 734 | 1 734 | 2 117 | 2 117 | 1 381 | 1 381 | |||
| FCF, bln rub | ? | 2 165 | 2 165 | 141.0 | 141.0 | -363.0 | -363.0 | |||
| Dividend payout, bln rub | 1 659 | 1 659 | 1 659 | 1 659 | 1 260 | 1 260 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 38.3% | 38.3% | 0.00% | 0.00% | 0.00% | -14.6% | ||||
| OPEX, bln rub | 26 879 | 27 295 | 34 205 | 33 954 | 40 600 | 40 598 | ||||
| Cost of production, bln rub | 104 437 | 104 437 | 112 009 | 112 009 | 121 134 | 121 135 | ||||
| R&D, bln rub | 307.0 | 307.0 | 371.0 | 371.0 | 0.000 | 0.000 | ||||
| Interest expenses, bln rub | 396.0 | 400.0 | 580.0 | 580.0 | 482.0 | 482.0 | ||||
| Assets, bln rub | 90 124 | 90 124 | 96 628 | 96 628 | 81 037 | 81 037 | ||||
| Net Assets, bln rub | ? | 29 366 | 29 366 | 20 021 | 20 021 | 10 445 | 10 445 | |||
| Debt, bln rub | 35 477 | 35 477 | 33 534 | 33 534 | 32 852 | 32 852 | ||||
| Cash, bln rub | 2 472 | 2 472 | 739.0 | 739.0 | 3 110 | 3 109 | ||||
| Net debt, bln rub | 33 005 | 33 005 | 32 795 | 32 795 | 29 742 | 29 743 | ||||
| Ordinary share price, rub | 35.1 | 35.1 | 25.3 | 25.3 | 9.25 | 21.5 | ||||
| Number of ordinary shares, mln | 864.4 | 864.4 | 863.2 | 863.2 | 863.1 | 863.7 | ||||
| Market cap, bln rub | 30 306 | 30 306 | 21 848 | 21 848 | 7 984 | 18 595 | ||||
| EV, bln rub | ? | 63 311 | 63 311 | 54 643 | 54 643 | 37 726 | 48 338 | |||
| Book value, bln rub | -3 644 | -3 644 | -21 801 | -21 801 | -18 034 | -18 034 | ||||
| EPS, rub | ? | 5.02 | 5.02 | -3.57 | -3.57 | -10.0 | -10.00 | |||
| FCF/share, rub | 2.50 | 2.50 | 0.16 | 0.16 | -0.42 | -0.42 | ||||
| BV/share, rub | -4.22 | -4.22 | -25.3 | -25.3 | -20.9 | -20.9 | ||||
| EBITDA margin, % | ? | 3.73% | 4.80% | -1.86% | 2.50% | -7.64% | -7.81% | |||
| Net margin, % | ? | 3.27% | 3.27% | -2.21% | -2.21% | -5.85% | -5.85% | |||
| FCF yield, % | ? | 7.14% | 7.14% | 0.65% | 0.65% | -4.55% | -1.95% | |||
| ROE, % | ? | 14.8% | 14.8% | -15.4% | -15.4% | -82.7% | -82.7% | |||
| ROA, % | ? | 4.81% | 4.81% | -3.19% | -3.19% | -10.7% | -10.7% | |||
| P/E | ? | 6.99 | 6.99 | -7.09 | -7.09 | -0.92 | -2.15 | |||
| P/FCF | 14.0 | 14.0 | 154.9 | 154.9 | -22.0 | -51.2 | ||||
| P/S | ? | 0.23 | 0.23 | 0.16 | 0.16 | 0.05 | 0.13 | |||
| P/BV | ? | -8.32 | -8.32 | -1.00 | -1.00 | -0.44 | -1.03 | |||
| EV/EBITDA | ? | 12.8 | 9.93 | -21.2 | 15.7 | -3.35 | -4.19 | |||
| Debt/EBITDA | 6.66 | 5.18 | -12.7 | 9.43 | -2.64 | -2.58 | ||||
| R&D/CAPEX, % | 17.7% | 17.7% | 17.5% | 17.5% | 0.00% | 0 | ||||
| CAPEX/Revenue, % | 1.31% | 1.31% | 1.52% | 1.52% | 0.94% | 0.94% | ||||
| Walgreens Boots Alliance shareholders | ||||||||||
